Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 2/20 | 0.61 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.61 |
| ▸ | CHRNA7 | P36544 | 6/20 | 0.59 |
| ▸ | APOBEC3A | P31941 | 3/20 | 0.49 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 2/20 | 0.49 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.44 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CCR5 | P51681 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10256901 | 1.00 | CHRNB2 (0.61) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Water SCHEMBL723735 | 0.98 | CHRNB2 (0.59) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL723900 | 0.98 | CHRNB2 (0.59) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Bromide SCHEMBL2450495 | 0.98 | CHRNB2 (0.59) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Iodide SCHEMBL11507837 | 0.98 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Water SCHEMBL8939227 | 0.98 | CHRNB2 (0.59) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| SCHEMBL3681307 | 0.98 | CHRNA7 (0.60) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Water SCHEMBL8939226 | 0.96 | CHRNB2 (0.58) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Hydrochloric Acid SCHEMBL2458828 | 0.96 | CHRNA7 (0.58) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G | |
| Iodide SCHEMBL3691022 | 0.96 | CHRNA7 (0.63) | CHRNB2CHRNA4CHRNA7APOBEC3AAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10836874-B2 | High performance cross-linked triblock cationic functionalized polymer for electrochemical applications, methods of making and methods of using | COLORADO SCHOOL OF MINES (US) | 2020-11-17 | — | — | US | claimed |
| US-20190100633-A1 | HIGH PERFORMANCE CROSS-LINKED TRIBLOCK CATIONIC FUNCTIONALIZED POLYMER FOR ELECTROCHEMICAL APPLICATIONS, METHODS OF MAKING AND METHODS OF USING | UNIVERSITY OF MASSACHUSETTS | 2019-04-04 | — | — | US | claimed |
| EP-1010667-B1 | Stannosilicate molecular sieves having the zeolite beta structure | UOP LLC (US) | 2003-10-08 | — | — | EP | claimed |
| EP-0684248-B1 | Process for the preparation of tertiary diarylalkylphosphines | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-29 | — | — | EP | claimed |
| US-5527967-A | Process for preparing tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | claimed |
| EP-0684248-A1 | Process for the preparation of tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-29 | — | — | EP | claimed |
| US-12036025-B2 | Bio-electrode, method for manufacturing bio-electrode, and method for measuring biological signal | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-16 | — | — | US | disclosed |
| US-20240215891-A1 | Bio-Electrode Composition, Bio-Electrode, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240215890-A1 | Bio-Electrode, Bio-Electrode Composition, And Method For Manufacturing Bio-Electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| CN-117936807-A | Preparation method and application of alkaline fuel cell catalyst layer containing high water-retaining property and high ion conductivity additive | 中国科学院山西煤炭化学研究所 | 2024-04-26 | — | — | CN | disclosed |
| CN-114732916-B | Targeted delivery of tertiary amine-containing drug substances | 西雅图基因公司 | 2023-12-19 | — | — | CN | disclosed |
| US-11839700-B2 | Bio-electrode composition, bio-electrode, and method for manufacturing a bio-electrode | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-12-12 | — | — | US | disclosed |
| US-11783958-B2 | Conductive wiring material composition, conductive wiring substrate and method for producing conductive wiring substrate | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-10 | — | — | US | disclosed |
| US-7312208-B2 | Quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-12-25 | — | — | US | disclosed |
| US-20070203115-A1 | Novel quaternary ammonium compounds | ASAHI KASEI PHARMA CORPORATION (JP) | 2007-08-30 | — | — | US | disclosed |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | ASHAI KASEI PHARAMA CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-20060186419-A1 | Light-emitting device | KABUSHIKI KAISHA TOSHIBA (JP) | 2006-08-24 | — | — | US | disclosed |
| EP-0684248-B1 | Process for the preparation of tertiary diarylalkylphosphines | CELANESE CHEM EUROPE GMBH (DE) | 2001-08-29 | — | — | EP | disclosed |
| US-5527967-A | Process for preparing tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1996-06-18 | — | — | US | disclosed |
| EP-0684248-A1 | Process for the preparation of tertiary diarylalkylphosphines | HOECHST AKTIENGESELLSCHAFT (DE) | 1995-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203115-A1 | Novel quaternary ammonium compounds | SLC10A2, SLC10A1, ABCB11 | CHRNB2 2528/4885CHRNA4 3536/4885CHRNA7 3399/4885 |
| US-20070190041-A1 | Novel benzothiazepine and bensothiepine compounds | SLC10A1, GOT1, CES1 | CHRNB2 4564/4885CHRNA4 3309/4885CHRNA7 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.